Odyssean »

Envista Hldgs Corp shares owned by Odyssean

Quarter-by-quarter ownership of Envista Hldgs Corp (NVST) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Envista Hldgs Corp

Tip: Access up to 7 years of quarterly data

All positions including Envista Hldgs Corp held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Envista Hldgs Corp by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $911k 35k 26.35

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Envista Hldgs Corp

BlackRock
Ariel Investments
Dimensional Fund Advisors
Morgan Stanley
Vanguard Portfolio Management
Vanguard Capital Management
Gates Capital Management
State Street Corporation
Alliancebernstein
Arrowstreet Capital, Limited Partnership
Franklin Resources
Victory Capital Management
Hanna Zanoni
Jpmorgan Chase & Co
Geode Capital Management

View all funds holding Envista Hldgs Corp